Žunić Miodrag, Vreča Nino, Bevc Sebastjan
Department of Anaesthesiology, Intensive care, and Pain management, University Medical Centre Maribor.
Faculty of Medicine, Univesity of Maribor, Maribor, Slovenia.
Blood Coagul Fibrinolysis. 2024 Oct 1;35(7):325-333. doi: 10.1097/MBC.0000000000001326. Epub 2024 Sep 30.
Factor XIII (FXIII), a plasma transglutaminase, is a coagulation factor that plays a crucial role in blood clotting and patient blood management. The studies have demonstrated that FXIII targets a wide range of additional substrates that have an important role in hemostasis, especially in posttraumatic patients, patients undergoing surgery or obstetrics, being involved in wound healing and tissue repair. Morover, FXIII deficiency has also been described and an extensive research has shown that FXIII deficiency is a rare coagulopathy that leads to longer bleeding time, perioperative and postoperative complications and slower wound healing. Present article aims to overview the diverse functions of FXIII and to highlight its role in patient blood management.
因子 XIII(FXIII)是一种血浆转谷氨酰胺酶,是一种凝血因子,在血液凝固和患者血液管理中起着关键作用。研究表明,FXIII 作用于多种在止血过程中具有重要作用的其他底物,尤其是在创伤后患者、接受手术或产科手术的患者中,参与伤口愈合和组织修复。此外,也有关于 FXIII 缺乏症的描述,大量研究表明,FXIII 缺乏症是一种罕见的凝血病,会导致出血时间延长、围手术期和术后并发症以及伤口愈合缓慢。本文旨在概述 FXIII 的多种功能,并强调其在患者血液管理中的作用。